Skip to main content
GutCited

N-Acetyl Cysteine (NAC) Hình ảnh

43 hình ảnh từ nghiên cứu có bình duyệt

Tất cả Psyllium Husk Bifidobacterium lactis Fructooligosaccharides (FOS) Lactobacillus plantarum Peppermint Oil Pancreatic Enzymes (Pancrelipase) Curcumin Vitamin A Medium-Chain Triglycerides (MCT Oil) Galactooligosaccharides (GOS) Lactobacillus gasseri Aloe Vera (Inner Leaf Gel) Alpha-Galactosidase Vitamin D L-Glutamine Inulin Ginger Lactase Berberine Omega-3 Fatty Acids (EPA/DHA) Bovine Colostrum Zinc Bifidobacterium bifidum Butyrate (Sodium/Calcium Butyrate) Bacillus coagulans Saccharomyces boulardii Lactobacillus acidophilus N-Acetyl Cysteine (NAC) Bifidobacterium longum
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Figure 7 Histological examination of the safety of selenium-containing amino acids. Lung, kidney, heart, liver, and spleen tissues were collected, H&E stained, and analyzed for the safety profile of selenium-containing amino acids. Scale bar is 100 μm
Figure 11

Figure 7 Histological examination of the safety of selenium-containing amino acids. Lung, kidney, heart, liver, and spleen tissues were collected, H&E stained, and analyzed for the safety profile of selenium-containing …

Selenium-Containing Amino Acids Protect Dextran Sulfate Sodium-Induced Colitis via Ameliorating Oxidative Stress …

Figure 6
Figure 6 Micrograph

Immunofluorescence imaging of Ku70/Ku80 localization in gastric epithelial cells, showing nuclear protein retention in alpha-lipoic acid-treated cells despite H. pylori infection.

α-Lipoic Acid Inhibits Apoptosis by Suppressing the Loss of Ku Proteins in …

Figure 7
Figure 7 Chart

Quantification of DNA double-strand break repair efficiency in H. pylori-infected gastric cells, indicating that alpha-lipoic acid supports the Ku-dependent non-homologous end joining pathway.

α-Lipoic Acid Inhibits Apoptosis by Suppressing the Loss of Ku Proteins in …

Figure 8
Figure 8 Chart

Cell viability analysis across different alpha-lipoic acid concentrations in H. pylori-infected gastric epithelial cells, establishing the effective dose range for cytoprotection.

α-Lipoic Acid Inhibits Apoptosis by Suppressing the Loss of Ku Proteins in …

Figure 9
Figure 9 Diagram

Signaling pathway analysis showing the molecular mechanism by which alpha-lipoic acid preserves Ku protein levels and inhibits apoptosis in H. pylori-infected gastric cells.

α-Lipoic Acid Inhibits Apoptosis by Suppressing the Loss of Ku Proteins in …

Figure 2
Figure 2 Micrograph

Liver histopathology from colitis-induced mice with and without oral NAC supplementation, evaluating extraintestinal hepatic manifestations including steatosis and inflammatory infiltration.

Extraintestinal Manifestations in Induced Colitis: Controversial Effects of N-Acetylcysteine on Colon, Liver, …

Figure 3
Figure 3 Micrograph

Kidney tissue histology showing renal changes associated with induced colitis, and the effects of N-acetylcysteine on renal inflammation and oxidative damage markers.

Extraintestinal Manifestations in Induced Colitis: Controversial Effects of N-Acetylcysteine on Colon, Liver, …

Figure 4
Figure 4 Chart

Oxidative stress biomarkers measured in colon, liver, and kidney tissues, comparing malondialdehyde (MDA) and glutathione (GSH) levels across treatment groups.

Extraintestinal Manifestations in Induced Colitis: Controversial Effects of N-Acetylcysteine on Colon, Liver, …

Figure 5
Figure 5 Chart

Inflammatory cytokine levels (such as TNF-alpha, IL-6, or IL-1beta) in colonic and extraintestinal tissues, assessing whether NAC modulates systemic inflammation originating from the gut.

Extraintestinal Manifestations in Induced Colitis: Controversial Effects of N-Acetylcysteine on Colon, Liver, …

Figure 6
Figure 6 Chart

Colon length measurements and macroscopic damage scoring in the colitis model, providing gross anatomical evidence of disease severity and NAC treatment response.

Extraintestinal Manifestations in Induced Colitis: Controversial Effects of N-Acetylcysteine on Colon, Liver, …

Figure 7
Figure 7 Chart

Summary of controversial findings regarding NAC's differential effects across organs, with protective trends observed in some tissues but potential adverse signals in others.

Extraintestinal Manifestations in Induced Colitis: Controversial Effects of N-Acetylcysteine on Colon, Liver, …

Scheme 1.Flowchart 1:The coding for mucopenetrative liposomal formulation compositions (MP1-MP6).The coding for mucopenetrative liposomal formulation compositions (MP1-MP6).
Figure 2

Scheme 1.Flowchart 1:The coding for mucopenetrative liposomal formulation compositions (MP1-MP6).The coding for mucopenetrative liposomal formulation compositions (MP1-MP6).

Liposomal Drug Delivery against Helicobacter pylori Using Furazolidone and N-Acetyl Cysteine in …

Figure 2. Transmission electron microscopic, TEM, images of mucopenetrative liposomes (A). MP3, cationic liposomes with Pluronic F-127 (B). MP1, neutral liposomes with Pluronic F-127. For formulations’ composition, refer to Table 1.
Figure 3

Figure 2. Transmission electron microscopic, TEM, images of mucopenetrative liposomes (A). MP3, cationic liposomes with Pluronic F-127 (B). MP1, neutral liposomes with Pluronic F-127. For formulations’ composition, refer to Table …

Liposomal Drug Delivery against Helicobacter pylori Using Furazolidone and N-Acetyl Cysteine in …

Figure 3. Diffusion of mucopenetrative liposomal particles from MP1 to MP6 through 1 mm thick sigma mucin type I in a silicon tube maintained at pH 6.0 at 37 ◦C at 1, 2, and 3 hours’ time (n = 3, mean ± SD shown). Abbreviations: MP1 (neutral with Pluronic
Figure 4

Figure 3. Diffusion of mucopenetrative liposomal particles from MP1 to MP6 through 1 mm thick sigma mucin type I in a silicon tube maintained at pH 6.0 at 37 ◦C …

Liposomal Drug Delivery against Helicobacter pylori Using Furazolidone and N-Acetyl Cysteine in …

Figure 5
Figure 5

Liposomal Drug Delivery against Helicobacter pylori Using Furazolidone and N-Acetyl Cysteine in …

Figure 7
Figure 7

Liposomal Drug Delivery against Helicobacter pylori Using Furazolidone and N-Acetyl Cysteine in …

Figure 8
Figure 8

Liposomal Drug Delivery against Helicobacter pylori Using Furazolidone and N-Acetyl Cysteine in …

Figure 9
Figure 9

Liposomal Drug Delivery against Helicobacter pylori Using Furazolidone and N-Acetyl Cysteine in …

Figure 11
Figure 11

Liposomal Drug Delivery against Helicobacter pylori Using Furazolidone and N-Acetyl Cysteine in …

Trang 2 / 2